Ellen Rovner
Nurse Practitioner · Indianapolis, INNPI 1396127015
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Pfizer accounts for 79.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $8,204 and has fallen 95.5% since, to $369 in 2025. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $365.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$9K
- Johnson & Johnson$1K
- GSK$242
- AstraZeneca$234
- Adaptive Biotechnologies Corporation$139
- Regeneron Healthcare Solutions, Inc.$122
- plus $100 from 1 others
What the payments were for
- Speaking & faculty fees$5,63550%
- Travel & lodging$3,39230%
- Food & beverage$2,00818%
- Education$2983%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 9 | $9,027 |
| Johnson & Johnson | 15 | $1,469 |
| GSK | 2 | $242 |
| AstraZeneca(2 entities) | 2 | $234 |
| Adaptive Biotechnologies Corporation | 1 | $139 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Incyte Corporation | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,334 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lenalidomide | 16 | $223,121 |
| Acyclovir | 27 | $704 |
| Oxycodone Hcl | 15 | $262 |
| Ondansetron Hcl | 12 | $255 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Indianapolis
- Kristi OrbaughIndianapolis$1.3M
- Kacy RogersIndianapolis$77K
- Brittany SavageIndianapolis$51K
- Jennifer MaahsIndianapolis$36K
- Dawn SteppIndianapolis$31K
- Angela PierceIndianapolis$19K
- Donna DoerfflerIndianapolis$13K
- Shannon ColterIndianapolis$12K
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.